Diagnostisches und therapeutisches management der oberen einflussstauung

Translated title of the contribution: Diagnostic and therapeutic management of superior vena cava syndrome

Wolfram Dempke, Curt Behrmann, Christoph Schöber, Thomas Büchele, Axel F Grothey, Hans Joachim Schmoll

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Superior vena cava syndrome (SVCS) is the clinical expression of obstruction of blood flow through the superior caval vein. In more than 80% of patients this complication is due to a malignant tumor, and in 60% of cases the first symptom of this tumor. Diagnosis and Treatment: If the clinical course of SVCS represents an absolute emergency, irradiation may have to be started immediately, even before the histologic diagnosis is established. Alternatively, expandable metallic stents have been used with considerable success for treatment of vena caval obstruction since patients respond immediately after stent implantation. For diagnosis, a chest X-ray and a CT scan should be performed. Chemotherapy is the treatment of choice for high-grade lymphomas, germ cell tumors and small-cell lung cancer since this modality is more effective than radiotherapy (response rate: 80%). For less chemotherapy responsive tumors radiotherapy is the primary treatment. Successful experience with thrombolytic agents is limited to treatment of catheter-induced SVCS, in contrast, only 20% of patients respond to thrombolytic therapy in the absence of a central catheter. Surgical resection of SVCS associated tumors has not improved survival rates and should be avoided.

Original languageGerman
Pages (from-to)681-684
Number of pages4
JournalMedizinische Klinik
Volume94
Issue number12
StatePublished - Dec 15 1999
Externally publishedYes

Fingerprint

Superior Vena Cava Syndrome
Tumors
Venae Cavae
Stents
Chemotherapy
Catheters
Radiotherapy
Neoplasms
Cells
Therapeutics
Drug Therapy
X Ray Computed Tomography
Fibrinolytic Agents
Computerized tomography
Germ Cell and Embryonal Neoplasms
Thrombolytic Therapy
Small Cell Lung Carcinoma
Non-Hodgkin's Lymphoma
Veins
Emergencies

Keywords

  • Diagnostic procedures
  • Therapeutic management
  • Vena cava superior syndrome

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry

Cite this

Dempke, W., Behrmann, C., Schöber, C., Büchele, T., Grothey, A. F., & Schmoll, H. J. (1999). Diagnostisches und therapeutisches management der oberen einflussstauung. Medizinische Klinik, 94(12), 681-684.

Diagnostisches und therapeutisches management der oberen einflussstauung. / Dempke, Wolfram; Behrmann, Curt; Schöber, Christoph; Büchele, Thomas; Grothey, Axel F; Schmoll, Hans Joachim.

In: Medizinische Klinik, Vol. 94, No. 12, 15.12.1999, p. 681-684.

Research output: Contribution to journalArticle

Dempke, W, Behrmann, C, Schöber, C, Büchele, T, Grothey, AF & Schmoll, HJ 1999, 'Diagnostisches und therapeutisches management der oberen einflussstauung', Medizinische Klinik, vol. 94, no. 12, pp. 681-684.
Dempke W, Behrmann C, Schöber C, Büchele T, Grothey AF, Schmoll HJ. Diagnostisches und therapeutisches management der oberen einflussstauung. Medizinische Klinik. 1999 Dec 15;94(12):681-684.
Dempke, Wolfram ; Behrmann, Curt ; Schöber, Christoph ; Büchele, Thomas ; Grothey, Axel F ; Schmoll, Hans Joachim. / Diagnostisches und therapeutisches management der oberen einflussstauung. In: Medizinische Klinik. 1999 ; Vol. 94, No. 12. pp. 681-684.
@article{3c917e656d3d43ae90757187371b033d,
title = "Diagnostisches und therapeutisches management der oberen einflussstauung",
abstract = "Background: Superior vena cava syndrome (SVCS) is the clinical expression of obstruction of blood flow through the superior caval vein. In more than 80{\%} of patients this complication is due to a malignant tumor, and in 60{\%} of cases the first symptom of this tumor. Diagnosis and Treatment: If the clinical course of SVCS represents an absolute emergency, irradiation may have to be started immediately, even before the histologic diagnosis is established. Alternatively, expandable metallic stents have been used with considerable success for treatment of vena caval obstruction since patients respond immediately after stent implantation. For diagnosis, a chest X-ray and a CT scan should be performed. Chemotherapy is the treatment of choice for high-grade lymphomas, germ cell tumors and small-cell lung cancer since this modality is more effective than radiotherapy (response rate: 80{\%}). For less chemotherapy responsive tumors radiotherapy is the primary treatment. Successful experience with thrombolytic agents is limited to treatment of catheter-induced SVCS, in contrast, only 20{\%} of patients respond to thrombolytic therapy in the absence of a central catheter. Surgical resection of SVCS associated tumors has not improved survival rates and should be avoided.",
keywords = "Diagnostic procedures, Therapeutic management, Vena cava superior syndrome",
author = "Wolfram Dempke and Curt Behrmann and Christoph Sch{\"o}ber and Thomas B{\"u}chele and Grothey, {Axel F} and Schmoll, {Hans Joachim}",
year = "1999",
month = "12",
day = "15",
language = "German",
volume = "94",
pages = "681--684",
journal = "Medizinische Klinik",
issn = "0723-5003",
publisher = "Urban und Vogel",
number = "12",

}

TY - JOUR

T1 - Diagnostisches und therapeutisches management der oberen einflussstauung

AU - Dempke, Wolfram

AU - Behrmann, Curt

AU - Schöber, Christoph

AU - Büchele, Thomas

AU - Grothey, Axel F

AU - Schmoll, Hans Joachim

PY - 1999/12/15

Y1 - 1999/12/15

N2 - Background: Superior vena cava syndrome (SVCS) is the clinical expression of obstruction of blood flow through the superior caval vein. In more than 80% of patients this complication is due to a malignant tumor, and in 60% of cases the first symptom of this tumor. Diagnosis and Treatment: If the clinical course of SVCS represents an absolute emergency, irradiation may have to be started immediately, even before the histologic diagnosis is established. Alternatively, expandable metallic stents have been used with considerable success for treatment of vena caval obstruction since patients respond immediately after stent implantation. For diagnosis, a chest X-ray and a CT scan should be performed. Chemotherapy is the treatment of choice for high-grade lymphomas, germ cell tumors and small-cell lung cancer since this modality is more effective than radiotherapy (response rate: 80%). For less chemotherapy responsive tumors radiotherapy is the primary treatment. Successful experience with thrombolytic agents is limited to treatment of catheter-induced SVCS, in contrast, only 20% of patients respond to thrombolytic therapy in the absence of a central catheter. Surgical resection of SVCS associated tumors has not improved survival rates and should be avoided.

AB - Background: Superior vena cava syndrome (SVCS) is the clinical expression of obstruction of blood flow through the superior caval vein. In more than 80% of patients this complication is due to a malignant tumor, and in 60% of cases the first symptom of this tumor. Diagnosis and Treatment: If the clinical course of SVCS represents an absolute emergency, irradiation may have to be started immediately, even before the histologic diagnosis is established. Alternatively, expandable metallic stents have been used with considerable success for treatment of vena caval obstruction since patients respond immediately after stent implantation. For diagnosis, a chest X-ray and a CT scan should be performed. Chemotherapy is the treatment of choice for high-grade lymphomas, germ cell tumors and small-cell lung cancer since this modality is more effective than radiotherapy (response rate: 80%). For less chemotherapy responsive tumors radiotherapy is the primary treatment. Successful experience with thrombolytic agents is limited to treatment of catheter-induced SVCS, in contrast, only 20% of patients respond to thrombolytic therapy in the absence of a central catheter. Surgical resection of SVCS associated tumors has not improved survival rates and should be avoided.

KW - Diagnostic procedures

KW - Therapeutic management

KW - Vena cava superior syndrome

UR - http://www.scopus.com/inward/record.url?scp=0033572939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033572939&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 681

EP - 684

JO - Medizinische Klinik

JF - Medizinische Klinik

SN - 0723-5003

IS - 12

ER -